A highly D(3)R-selective and efficacious partial agonist (S)-ABS01-113 compared to its D(3)R-selective antagonist enantiomer (R)-ABS01-113 as potential treatments for opioid use disorder

The non-medical use of opioids has become a national crisis in the USA. Developing non-opioid pharmacotherapies for controlling this opioid epidemic is urgent. Dopamine D(3) receptor (D(3)R) antagonists and low efficacy partial agonists have shown promising profiles in animal models of opioid use di...

Descripción completa

Detalles Bibliográficos
Autores principales: Galaj, Ewa, Bi, Guo-Hua, Klein, Benjamin, Hempel, Briana, Shaik, Anver Basha, Gogarnoiu, Emma S., Friedman, Jacob, Lam, Jenny, Rais, Rana, Reed, John F., Bloom, Shelley H., Swanson, Tracy L., Schmachtenberg, Jennifer L., Eshleman, Amy J., Janowsky, Aaron, Xi, Zheng-Xiong, Newman, Amy Hauck
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309443/
https://www.ncbi.nlm.nih.gov/pubmed/35879349
http://dx.doi.org/10.1038/s41386-022-01379-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309443/
https://www.ncbi.nlm.nih.gov/pubmed/35879349
http://dx.doi.org/10.1038/s41386-022-01379-1

Ejemplares similares